In this webinar, learn about the nature of CAR-T therapy and how the transition from oncology to non-oncology indications presents challenges and complexities in running clinical trials. Attendees will understand the latest developments shaping oncology research and future prospects in cell and gene therapy. The featured speakers will explore how lessons learned from oncology can be translated into other therapeutic areas for enhancing patient outcomes.
TORONTO, June 5, 2024 /PRNewswire-PRWeb/ -- Discover an insightful webinar delving into the expanding horizons of CAR-T therapy beyond oncology.
CAR-T therapy stands at the forefront of medical innovation offering novel treatments for cancer and promising avenues for addressing a wide array of non-oncological diseases. Explore how these therapies are poised to revolutionize treatment paradigms as well as the adaptation of CAR-T therapy to immunomodulatory approaches for autoimmune diseases, infectious diseases, neurodegenerative disorders, cardiovascular diseases and other non-oncologic conditions.
This webinar focuses on the seamless transition of oncology expertise into non-oncological realms, illustrating how clinical development and operational insights gleaned from managing cancer treatments can be effectively applied to enhance patient care in other disease contexts. Drawing parallels between the complexities of oncology clinical development and the challenges inherent in other therapeutic areas, the expert speakers will elucidate the invaluable lessons learned and strategies devised within the field of oncology that can be leveraged to optimize outcomes in diverse medical domains.
The expert speakers will examine the evolutionary trajectory of biologic therapies, noting how less complex treatments such as monoclonal antibodies have successfully expanded beyond oncology into rheumatology, autoimmune diseases and beyond. This journey serves as a testament to the adaptability and versatility of advanced therapeutic modalities, hinting at a future where cell and gene therapies seamlessly integrate into the fabric of modern medicine, offering hope and healing to patients worldwide.
They will also explore the current and future landscape of CAR-T therapy, highlighting its diverse applications and potential. From revolutionizing treatment approaches in non-oncological diseases to leveraging operational oncology experience for broader therapeutic insights, this webinar will provide valuable lessons and insights into the transformative power of CAR-T therapy across various therapeutics.
Register for this webinar today to gain insights into the adaptation of CAR T-cell therapy to various non-oncologic conditions.
Join experts from Fortrea, Frederick Derosier, DO, Vice President, Rare Disease, Advanced Therapies, and Pediatrics, Dr. Brian Hamilton, Senior Medical Director; and Jan Skoumal, Executive Director, Global Project Delivery, Oncology, for the live webinar on Wednesday, June 19, 2024, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Exploring Applications of CAR-T Therapy Outside Oncology: Strategies for Applying Lessons Learned.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
SOURCE Xtalks
Share this article